Sort by
Keyphrases
Weight Loss
100%
Clinical Effect
100%
Non-alcoholic Fatty Liver Disease (NAFLD)
100%
Pathophysiology
100%
Clinical Management
100%
Liver Biopsy
22%
Metabolic Syndrome
22%
Nonalcoholic Steatohepatitis
22%
Advanced Fibrosis
22%
Public Health
11%
Western World
11%
Deleterious Effects
11%
Increasing Prevalence
11%
Inflammatory Process
11%
Treatment Options
11%
Hypertension
11%
Liver
11%
Fibrosis
11%
Steatosis
11%
Dietary Modification
11%
Patient Selection
11%
Hyperglycemia
11%
Liver Function Tests
11%
Obesity Prevalence
11%
Severe Disease
11%
Lifestyle Intervention
11%
Accurate Diagnosis
11%
Cirrhosis
11%
Dyslipidemia
11%
Balloon
11%
Diabetes Prevalence
11%
Chronic Liver Disease
11%
Metabolic Disorders
11%
Liver-related Mortality
11%
Inflammatory Fibrosis
11%
Vitamin E
11%
Hepatic Steatosis
11%
Pioglitazone
11%
Dietary Recommendations
11%
Mild Forms
11%
Liver Failure
11%
Histologic Evaluation
11%
Central Obesity
11%
Dietary Lifestyle
11%
Hepatocyte Injury
11%
Lobular Inflammation
11%
Medicine and Dentistry
Nonalcoholic Fatty Liver
100%
Pathophysiology
100%
Clinical Management
100%
Fibrosis
36%
Liver Biopsy
18%
Metabolic Syndrome
18%
Prevalence
9%
Public Health
9%
Serositis
9%
Steatosis
9%
Fatty Liver
9%
Hyperglycemia
9%
Liver Function Test
9%
Diabetes
9%
Water-Electrolyte Imbalance
9%
Lifestyle Intervention
9%
Alpha Tocopherol
9%
Dyslipidemia
9%
Liver Cell Damage
9%
Chronic Liver Disease
9%
Liver Cirrhosis
9%
Liver Failure
9%
Pioglitazone
9%
Pharmacology, Toxicology and Pharmaceutical Science
Nonalcoholic Fatty Liver
100%
Pathophysiology
100%
Fibrosis
36%
Metabolic Syndrome X
18%
Inflammation
18%
Chronic Liver Disease
9%
Fatty Liver
9%
Prevalence
9%
Pioglitazone
9%
Liver Cell Damage
9%
Liver Failure
9%
Liver Cirrhosis
9%
Alpha Tocopherol
9%
Metabolic Disorder
9%
Steatosis
9%
Dyslipidemia
9%
Hyperglycemia
9%